Medroxyprogesterone Acetate Injectable Suspension Recalled Due to Cold Chain Disruption
Medroxyprogesterone Acetate Injectable Suspension (150 mg/mL) distributed to medical facilities in Mississippi and Florida is recalled because severe thunderstorms caused shipping delays that may have compromised the product's storage conditions and safety.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall, and the source text contains no reports of actual illness or injury. The hazard is potential—storage condition deviation that may have affected product stability—but no adverse health consequences have been reported, making this a precautionary recall.
Plain-English summary
Mckesson Medical-Surgical Inc. is recalling Medroxyprogesterone Acetate Injectable Suspension, USP, 150 mg/mL, 1 mL Single-Dose Vials (NDC 55150-0330-01, Lot #1MP24042, expiration 6/30/26), manufactured in India for Eugia US LLC of East Windsor, New Jersey.
Severe thunderstorms caused transit delays for shipments dispatched on April 2, 2025, which were delivered after the specified 48-hour delivery window on April 7 and 8, 2025. Because the affected products may not have been stored at the recommended labeled storage conditions during transport, the safety, quality, identity, potency, and purity of the product may have been impacted.
The recalled product was distributed to medical facilities in Mississippi and Florida. Patients and healthcare providers who have received this medication should contact their healthcare provider for guidance. Medical facilities should check their inventory against the identified lot number and quarantine affected units.
The recalled product
- Product
- Medroxyprogesterone Acetate Injectable Suspension, USP, 150 mg / mL, 1 mL Single-Dose Vial, Rx only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, NDC 55150-0330-01
- Manufacturer
- Mckesson Medical-Surgical Inc. Corporate Office
- Category
- Drug — Injectable Suspension
- Hazard
- cold-chain-disruption
- potency-degradation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 1MP24042
- Exp 6/30/26
Distribution
Distributed in 2 states:
- FL
- MS
Related recalls
Same category
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- ModerateQuality Choice Earwax Removal Kit Carbamide Peroxide Subpotent Drug Recall
FDA (Drugs) · 2026-07-22
- ModerateLeader Carbamide Peroxide Earwax Removal Kit Recalled for Subpotency
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- ModerateClinere Ear Wax Remover Recalled for Subpotent Carbamide Peroxide
FDA (Drugs) · 2026-07-22